The Erythromycin 2%/Ketoconazole 2%/Ciprofloxacin 1%/DMSO Nail Gel is a semisolid formulation dispensed via a pump mechanism for easy and precise application. This formulation is designed for targeted treatment and absorption of active ingredients, primarily used for conditions such as onychomycosis, tinea pedis, tinea versicolor, tinea cruris, and tinea corporis.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Erythromycin 2%/Ketoconazole 2%/Ciprofloxacin 1%/DMSO Nail Gel is a potent compounded formulation designed to address a range of skin and nail conditions. This unique blend of medications is specifically formulated to combat bacterial and fungal infections, including those instigated by Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. It also proves effective against dermatophyte infections such as athlete's foot and ringworm, as well as onychomycosis, a fungal infection of the nails.
The formulation combines the broad-spectrum antibacterial and antifungal properties of erythromycin and ketoconazole, with the added antibacterial strength of ciprofloxacin. The inclusion of DMSO enhances the penetration of these medications into the skin and nails, thereby amplifying their effectiveness. This semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients in a gel-like consistency.
The recommended application is twice daily to the affected area for a duration of up to four weeks. For any queries regarding this formulation or its usage, please do not hesitate to contact us at Bayview Pharmacy.
This compounded formulation of Erythromycin 2%/Ketoconazole 2%/Ciprofloxacin 1%/DMSO Nail Gel is a targeted treatment for fungal and bacterial infections of the nails, including conditions such as onychomycosis and paronychia.
However, it is crucial to note that this formulation is not suitable for patients with known hypersensitivity to any of its components. It is also not recommended for patients with a history of liver disease or renal impairment. Therefore, a thorough medical history should be taken into account before prescribing this medication.
Patients are advised to apply the gel to the affected area twice daily, continuing its use for at least two weeks after the symptoms have subsided. It is also important to avoid contact with the eyes and mucous membranes during application.
Furthermore, this formulation may interact with other medications, including antifungal medications, antibiotics, and anticoagulants. Therefore, patients should be encouraged to inform their healthcare provider of any other medications they are currently taking before starting this treatment.
If there are any questions or concerns regarding this formulation or its potential interactions, it is recommended to seek professional advice. It is always important to ensure that the benefits of a medication outweigh its potential risks, and this can only be determined through a comprehensive consultation with a healthcare provider.
Erythromycin 2%/Ketoconazole 2%/Ciprofloxacin 1%/DMSO Nail Gel is a compounded formulation designed to combat fungal infections of the nails. This unique blend combines the antifungal properties of Erythromycin and Ketoconazole with the antibacterial prowess of Ciprofloxacin. The inclusion of DMSO serves to enhance the absorption of these active ingredients into the nail and surrounding skin.
This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application. The gel-like consistency ensures that the medication adheres well to the nail and skin, providing a sustained release of the active ingredients. It is recommended to apply this medication directly to the affected nail and surrounding skin twice daily. Prior to application, it is crucial to ensure that the nail is completely dry.
The medication should be applied in a thin layer and allowed to dry before covering with a bandage or other covering. It is important to continue using the medication for the full course of treatment, even if the symptoms improve. Discontinuing the treatment prematurely may result in the infection returning or becoming resistant to the medication.
If the symptoms do not improve after two weeks of treatment, it is important to contact your healthcare provider. They may need to reassess your condition and possibly adjust your treatment plan. This formulation is a testament to the power of compounded medications.
This compounded formulation of Erythromycin 2%/Ketoconazole 2%/Ciprofloxacin 1%/DMSO Nail Gel is a semisolid formulation dispensed through a pump mechanism. It is designed for easy and precise application on the skin, facilitating targeted treatment or absorption of active ingredients in a gel-like consistency.
The gel is applied directly to the affected area twice daily for up to four weeks. It should be gently rubbed in until completely absorbed. It is crucial to avoid application on broken skin or open wounds, and to prevent contact with the eyes, nose, and mouth. In case of accidental contact, rinse thoroughly with water. Discontinue use and consult your healthcare provider if any irritation or redness occurs.
For any queries regarding the use of this formulation, please contact us at Bayview Pharmacy.
This is a semisolid formulation that combines Erythromycin, Ketoconazole, Ciprofloxacin, and DMSO in a gel-like consistency. It is designed for easy and precise application on the skin for targeted treatment.
This formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The active ingredients in this formulation are Erythromycin, Ketoconazole, Ciprofloxacin, and DMSO.
DMSO is used as a solvent to help the other active ingredients penetrate the skin more effectively.
You should apply this formulation directly to the affected area as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
This formulation has a gel-like consistency, which allows it to be easily spread on the skin for targeted treatment.
This formulation is specifically designed for use on the nails. However, it may be used for other skin conditions as directed by your healthcare provider.
Always use this formulation as directed by your healthcare provider. Avoid contact with eyes and mucous membranes. If irritation or sensitivity develops, stop using the product and consult your healthcare provider.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store this formulation at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)